Search
Feed aggregator
Where Do We Go From Here? The Future of Women's Health
Where Do We Go From Here? The Future of Women's Health 4/25/2024
Novartis Beats Q1 Expectations, Raises 2024 Outlook on Strong Drug Sales
Novartis Beats Q1 Expectations, Raises 2024 Outlook on Strong Drug Sales 4/23/2024
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win 4/23/2024
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates 4/23/2024
ImmunityBio Wins FDA Approval for First IL-15 Superagonist for NMIBC
ImmunityBio Wins FDA Approval for First IL-15 Superagonist for NMIBC 4/23/2024
FDA Rejects Abeona’s Epidermolysis Bullosa Cell Therapy, Asks for CMC Data
FDA Rejects Abeona’s Epidermolysis Bullosa Cell Therapy, Asks for CMC Data 4/23/2024
Supreme Court Denies Vanda’s Petition in Hetlioz Patent Case Against Teva
Supreme Court Denies Vanda’s Petition in Hetlioz Patent Case Against Teva 4/23/2024
Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US
Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US 4/19/2024
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies 4/19/2024
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC 4/19/2024
Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring
Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring 4/19/2024
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations? 4/19/2024
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies 4/19/2024
Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market
Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market 4/18/2024
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win 4/18/2024
Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition
Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition 4/18/2024
Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA
Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA 4/18/2024
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch 4/18/2024
Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS
Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS 4/18/2024
Bioversity Program Preps Grads for Early-Career Life Science Roles
Bioversity Program Preps Grads for Early-Career Life Science Roles 4/18/2024
World Pharma News
- How the cheese-noodle principle could help counter Alzheimer's
- New 'sensor' lets researchers watch DNA repair in real time
- The immune system creates its own targets within viruses
- Targeted drug could benefit young patients with invasive sarcoma
- Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders